Biblioteca Humberto Rosselli Quijano
Información del autor
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
[artículo]
| Título : |
Are lorazepam-induced deficits in attention similar to those resulting from aging? |
| Tipo de documento: |
texto impreso |
| Autores: |
Emma Fluck, Autor ; Cathy Fernandes, Autor ; Sandra E. File, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 126-130 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Envejecimiento, Atención, Moduladores GABA, Lorazepam. |
| Resumen: |
The purpose of this experiment was to compare, in three tasks of attention, the impairment caused by lorazepam (1 and 2.5 mg) administered to young volunteers with the impairment that results from aging. Performance on digit cancellation (DC), digit-symbol substitution (DSS), and Paced Auditory Serial Addition Task (PASAT) was significantly impaired by lorazepam (2.5 mg) and was significantly worse in the middle-aged group (mean ± SEM, aged 58.9 ± 0.8 years) compared with the younger, IQ-matched group (20.7 ± 0.2 years). |
| Link: |
./index.php?lvl=notice_display&id=31115 |
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 126-130
[artículo] Are lorazepam-induced deficits in attention similar to those resulting from aging? [texto impreso] / Emma Fluck, Autor ; Cathy Fernandes, Autor ; Sandra E. File, Autor . - 2023 . - pp. 126-130. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 126-130
| Palabras clave: |
Envejecimiento, Atención, Moduladores GABA, Lorazepam. |
| Resumen: |
The purpose of this experiment was to compare, in three tasks of attention, the impairment caused by lorazepam (1 and 2.5 mg) administered to young volunteers with the impairment that results from aging. Performance on digit cancellation (DC), digit-symbol substitution (DSS), and Paced Auditory Serial Addition Task (PASAT) was significantly impaired by lorazepam (2.5 mg) and was significantly worse in the middle-aged group (mean ± SEM, aged 58.9 ± 0.8 years) compared with the younger, IQ-matched group (20.7 ± 0.2 years). |
| Link: |
./index.php?lvl=notice_display&id=31115 |
|
